These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 2573649)

  • 1. Radiation biology of human tumour xenografts.
    Rofstad EK
    Int J Radiat Biol; 1989 Nov; 56(5):573-81. PubMed ID: 2573649
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Human tumour xenografts in radiotherapeutic research.
    Rofstad EK
    Radiother Oncol; 1985 Jan; 3(1):35-46. PubMed ID: 3975440
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tumour growth delay following single dose irradiation of human melanoma xenografts. Correlations with tumour growth parameters, vascular structure and cellular radiosensitivity.
    Rofstad EK; Brustad T
    Br J Cancer; 1985 Feb; 51(2):201-10. PubMed ID: 3966977
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Radioresponsiveness of human melanoma xenografts given fractionated irradiation in vivo--relationship to the initial slope of the cell survival curves in vitro.
    Rofstad EK; Brustad T
    Radiother Oncol; 1987 May; 9(1):45-56. PubMed ID: 3602429
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of the radiobiological properties of human tumour xenografts and rodent tumours.
    Guichard M
    Int J Radiat Biol; 1989 Nov; 56(5):583-6. PubMed ID: 2573650
    [No Abstract]   [Full Text] [Related]  

  • 6. Growth rates or radiobiological hypoxia are not correlated with local metabolite content in human melanoma xenografts with similar vascular network.
    Kroeger M; Walenta S; Rofstad EK; Mueller-Klieser W
    Br J Cancer; 1995 Oct; 72(4):912-6. PubMed ID: 7547239
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effect of hydralazine on blood flow and misonidazole toxicity in human tumour xenografts.
    Guichard M; Lespinasse F; Trotter M; Durand R; Chaplin D
    Radiother Oncol; 1991 Feb; 20(2):117-23. PubMed ID: 2031087
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Radiation response of multicellular spheroids initiated from five human melanoma xenograft lines. Relationship to the radioresponsiveness in vivo.
    Rofstad EK; Wahl A; Brustad T
    Br J Radiol; 1986 Oct; 59(706):1023-9. PubMed ID: 3768626
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The radiobiology of human neuroblastoma.
    Deacon JM; Wilson PA; Peckham MJ
    Radiother Oncol; 1985 Apr; 3(3):201-9. PubMed ID: 4001442
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transiently hypoxic tumour cell turnover and radiation sensitivity in human tumour xenografts.
    Wadsworth BJ; Lee CM; Bennewith KL
    Br J Cancer; 2022 Jun; 126(11):1616-1626. PubMed ID: 35031765
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The human tumour xenograft--a valid model in experimental chemotherapy?
    Shorthouse AJ; Smyth JF; Steel GG; Ellison M; Mills J; Peckham MJ
    Br J Surg; 1980 Oct; 67(10):715-22. PubMed ID: 6253000
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Response of U87 glioma xenografts treated with concurrent rapamycin and fractionated radiotherapy: possible role for thrombosis.
    Weppler SA; Krause M; Zyromska A; Lambin P; Baumann M; Wouters BG
    Radiother Oncol; 2007 Jan; 82(1):96-104. PubMed ID: 17161482
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effect of combined nicotinamide and carbogen treatments in human tumour xenografts: oxygenation and tumour control studies.
    Stüben G; Stuschke M; Knühmann K; Horsman MR; Sack H
    Radiother Oncol; 1998 Aug; 48(2):143-8. PubMed ID: 9783885
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunotherapy of human tumour xenografts overexpressing the EGF receptor with rat antibodies that block growth factor-receptor interaction.
    Modjtahedi H; Eccles S; Box G; Styles J; Dean C
    Br J Cancer; 1993 Feb; 67(2):254-61. PubMed ID: 7679281
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Xenografts of five human leiomyosarcomas: radiation response after 60cobalt- and d(14)+Be neutron single doses.
    Budach V; Stuschke M; Budach W; Streffer C; Sack H
    Strahlenther Onkol; 1990 Jan; 166(1):14-7. PubMed ID: 2105535
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The response to chemotherapy of a variety of human tumour xenografts.
    Steel GG; Courtenay VD; Peckham MJ
    Br J Cancer; 1983 Jan; 47(1):1-13. PubMed ID: 6336942
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Radiation and heat sensitivity of cells from two slowly growing human melanoma xenografts.
    Rofstad EK; Wahl A; Brustad T
    Br J Cancer; 1984 Jun; 49(6):745-52. PubMed ID: 6733021
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Preclinical phase II study of ifosfamide in human tumour xenografts in vivo.
    Berger DP; Fiebig HH; Winterhalter BR; Wallbrecher E; Henss H
    Cancer Chemother Pharmacol; 1990; 26 Suppl():S7-11. PubMed ID: 2347054
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Radiobiologic studies of radioimmunotherapy and external beam radiotherapy in vitro and in vivo in human renal cell carcinoma xenografts.
    Ning S; Trisler K; Wessels BW; Knox SJ
    Cancer; 1997 Dec; 80(12 Suppl):2519-28. PubMed ID: 9406705
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Radioimmunotherapy of human head and neck squamous cell carcinoma xenografts with 131I-labelled monoclonal antibody E48 IgG.
    Gerretsen M; Schrijvers AH; van Walsum M; Braakhuis BJ; Quak JJ; Meijer CJ; Snow GB; van Dongen GA
    Br J Cancer; 1992 Sep; 66(3):496-502. PubMed ID: 1520586
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.